MedAppWAR:MDA +3.09%40 Market Cap is zł50.03 Mil as of Jun. 28, 2026. GuruFocus rates WAR:MDA with a GF Score™ of 40/100 and a GF Value™ of zł0.25 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 694 Healthcare Providers & Services companies, MedApp ranks worse than 79.54% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MedApp's share price for the quarter that ended in Mar. 2026 was zł0.226. MedApp's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 250.13 Mil. Therefore, MedApp's market cap for the quarter that ended in Mar. 2026 was zł56.53 Mil.
MedApp's quarterly market cap
declined
from Sep. 2025 (zł44.52 Mil) to Dec. 2025 (zł21.66 Mil) but then
increased
from Dec. 2025 (zł21.66 Mil) to Mar. 2026 (zł56.53 Mil).
MedApp's annual market cap
declined
from Dec. 2023 (zł86.05 Mil) to Dec. 2024 (zł39.27 Mil) and
declined
from Dec. 2024 (zł39.27 Mil) to Dec. 2025 (zł21.66 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MedApp's Enterprise Value for Today is zł54.01 Mil.
MedApp (WAR:MDA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
MedApp Market Cap Related Terms
MedApp Market Cap Historical Data
* Premium members only.
The historical data trend for MedApp's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, MedApp's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedApp Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedApp's Market Cap distribution charts can be found below:
* The bar in red indicates where MedApp's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
MedApp's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedApp (WAR:MDA) has a Market Cap of zł50.03 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MedApp and its competitors. According to the industry distribution chart, MedApp ranks #552 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 79.5%.
Is MedApp's Market Cap too high?
MedApp's current Market Cap is zł50.03 Mil. Based on the distribution chart, MedApp ranks #552 out of 694 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MedApp has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MedApp's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedApp ranks #552 out of 694 companies for Market Cap. This places MedApp in the lower half of its industry. The industry median Market Cap is 92.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 92.82, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on MedApp and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 92.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedApp's current Market Cap is zł50.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedApp stock overvalued right now?
Based on GuruFocus' analysis, MedApp (WAR:MDA) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.25, compared to a current price of zł0.20 — trading 20% below its estimated fair value. The current Market Cap is zł50.03 Mil. MedApp's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For MedApp (WAR:MDA), the current Market Cap is zł50.03 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedApp (WAR:MDA) Overvalued in 2026?
Based on GuruFocus' analysis, MedApp stock appears to be undervalued.
The current stock price of zł0.20 is trading 20% below its estimated GF Value™ of zł0.25.
GuruFocus considers MedApp to be Modestly Undervalued.
Key valuation signals for WAR:MDA:
Market Cap: zł50.03 Mil
GF Value™: zł0.25 vs. price of zł0.20 (20% below fair value)
No single metric tells the full story. See the WAR:MDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MDA has been successfully added to your 
